Boston Scientific (BSX) Other Operating Expenses (2009 - 2026)

Boston Scientific has disclosed Other Operating Expenses across 17 years of filings, most recently posting $237.0 million for Q2 2026.

• In Q2 2026, Other Operating Expenses fell 15.36% year-over-year to $237.0 million; the TTM figure through Jun 2026 stood at $1.0 billion (down 1.05% YoY), while the FY2025 annual figure was $1.1 billion, changed N/A from the prior year.
• Other Operating Expenses came in at $237.0 million for Q2 2026 at Boston Scientific, up from $213.0 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $500.0 million in Q2 2024 to a low of -$22.0 million in Q4 2022.
• Average Other Operating Expenses over 5 years is $255.3 million, with a median of $246.0 million recorded in 2023.
• Year-over-year, Other Operating Expenses slumped 173.33% in 2022 and surged 1250.0% in 2023.
• Over 5 years, Other Operating Expenses stood at -$22.0 million in 2022, then surged by 1250.0% to $253.0 million in 2023, then jumped by 36.36% to $345.0 million in 2024, then slipped by 0.87% to $342.0 million in 2025, then sank by 30.7% to $237.0 million in 2026.
• Per Business Quant data, the three most recent Other Operating Expenses figures were $237.0 million in Q2 2026, $213.0 million in Q1 2026, and $342.0 million in Q4 2025.